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ABSTRACT 53 
Cell adhesion molecule 1 (CADM1) is aberrantly expressed by T-cell neoplasms such as 54 
adult T-cell leukemia/lymphoma (ATLL) and mycosis fungoides (MF). We studied the 55 
expression of CADM1 and its splicing variants in Sézary syndrome (SS), MF, other 56 
cutaneous T-cell lymphoma (CTCL), and cell lines derived from T- and B-cell 57 
lymphomas. Soluble CADM1 was measured in the patients’ sera. CADM1+ cells in the 58 
blood and skin lesions were examined by flow cytometry and immunostaining, 59 
respectively. Soluble CADM1 was measured by ELISA, and the splicing variants of 60 
CADM1 transcripts were determined by reverse transcriptase-polymerase chain 61 
reaction, followed by sequencing. As a result, circulating CADM1+ cells were 62 
significantly increased in 7 of 10 patients with SS, ranging from 7.9% to 74.5% of the 63 
CD3+CD4+ fractions (median; 33.7%) (cut off value; 6.5%). The percentages of 64 
CADM1+ cells were usually less than those of circulating Sézary cells. CADM1 was 65 
expressed, to various degrees, in 6 of 9 T-cell lines derived from SS, MF, ATLL, and 66 
anaplastic large cell lymphoma (ALCL), but negative in B-cell lymphoma-derived cell 67 
lines. CADM1+ cells were present in the skin infiltrates of MF, SS, ATLL and ALCL. 68 
Serum levels of soluble CADM1 were not significantly elevated in SS/MF. Three major 69 
splicing variants of CADM1 expressed by neoplastic T cells contained different 70 
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combinations of the exons 7, 8, 9 and 11, including a putative oncogenic variant 71 
composed of exons 7-8-9-11. In conclusion, CADM1 is frequently expressed in Sézary 72 
cells and cell lines from CTCL. 73 
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